Literature DB >> 11112224

Ovarian serous borderline tumors: the citadel defended.

R J Kurman, J D Seidman.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11112224     DOI： 10.1016/s0046-8177(00)80020-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  3 in total

1.  Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.

Authors:  Russell Vang; Charlotte G Hannibal; Jette Junge; Kirsten Frederiksen; Susanne K Kjaer; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2017-06       Impact factor: 6.394

2.  Laparoscopic restaging of borderline ovarian tumors.

Authors:  E Daraï; L Tulpin; H Prugnolle; A Cortez; G Dubernard
Journal:  Surg Endosc       Date:  2007-05-19       Impact factor: 4.584

3.  HER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancer.

Authors:  Wen-Yee Chay; Sung-Hock Chew; Whee-Sze Ong; Inny Busmanis; Xinyun Li; Sharyl Thung; Lynette Ngo; Sheow-Lei Lim; Yong-Kuei Lim; Yin-Nin Chia; Elisa Koh; Cindy Pang; Lay-Tin Soh; Jin Wang; Tew-Hong Ho; Sun-Kuie Tay; Soo-Kim Lim-Tan; Kiat-Hon Lim; John Whay-Kuang Chia; Liang-Kee Goh
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.